Search results

Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

A high-level strategy for ANSTO to support environmental sustainability

Outstanding individuals and teams have been recognised for their outstanding work, innovation, excellence in the 2025 ANSTO Awards. 

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.

In part 1 of this two-part series, ANSTO scientists from across the organisation became film critics to review Christopher Nolan’s new movie, Oppenheimer, which explores the life of the director of the Manhattan Project to develop an atomic weapon.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

The Nobel Prizes for Physics, Chemistry and Medicine have been announced. 

The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.